ATLANTA, Sept. 8 /PRNewswire/ -- CeloNova BioSciences, Inc. ("CeloNova"), a leading developer of innovative medical devices, today unveiled the world's first fully color-coded line of embolic particles, Embozene(TM) Color-Advanced Microspheres, at the annual meeting of the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) in Athens, Greece.
Embolic microspheres are used to treat liver cancer, fibroids, and other hypervascularized tumors. "With the release of Color-Advanced Microspheres, interventional radiologists now have available a highly biocompatible, precisely calibrated embolic particle that offers the unique safety and convenience advantages of being color coded by microsphere size. Nothing else on the embolic market offers such a compelling package of superior clinical performance combined with total ease-of-use for the physician," stated CeloNova President and Chief Executive Officer Thomas A. Gordy.
Ranging in size from 40 microns (approximately the diameter of a human hair) to 900 microns and based on the company's already well-received opaque microspherical product, Embozene(TM) Color-Advanced Microspheres now offer the additional benefit of enhanced visibility and instant, effortless identification of microsphere size by color. This means:
-- Immediate visual confirmation that the microspheres are properly mixed
-- Reduced risk of cross-contamination during the procedure;
-- A reduced risk of injecting too many or too few microspheres because
they are clearly visible;
-- No more waste due to uncertainty when a physician is operating with
multiple microsphere sizes.
Gordy continued: "From the beginning, CeloNova has operated on the
principle that our products would be designed with class-leading
|SOURCE CeloNova BioSciences, Inc.|
Copyright©2007 PR Newswire.
All rights reserved